Waldenstrom Macroglobulinemia, also known as Lymphoplasmacytic Lymphoma, is a rare type of cancer that affects the lymphatic system. It is characterized by the overproduction of abnormal white blood cells called lymphoplasmacytic cells, which produce excessive amounts of a protein called monoclonal immunoglobulin M (IgM).
Waldenstrom Macroglobulinemia is often referred to as WM for short. This condition is classified as a type of non-Hodgkin lymphoma, a group of cancers that originate in the lymphocytes, a type of white blood cell. WM primarily affects the bone marrow, where the abnormal lymphoplasmacytic cells accumulate and interfere with the production of normal blood cells.
There are several synonyms or alternative names used to refer to Waldenstrom Macroglobulinemia. These include:
It is important to note that while these terms are used interchangeably, they all refer to the same disease, Waldenstrom Macroglobulinemia. The choice of terminology may vary depending on the context or preference of healthcare professionals.